The Impact of New FDA Leadership: Catalyst to Speak at Biotech Showcase Conference

Come and join us on Jan. 8 as Catalyst President Nancy Bradish Myers speaks as part of a panel on “The impact of new leadership and new initiatives at FDA.”

The panel, which is part of the Biotech Showcase in San Francisco, will be moderated by Philip Katz, Partner and Head of FDA Pharmaceutical and Biotechnology Practice, Hogan Lovells.

Her fellow panelists include:

  • Gayatri Rao, former Director for the Office of Orphan Products Development, FDA
  • John Jenkins, Principal, Greenleaf Health (formerly Director, Office of New Drugs at FDA)
  • David Horowitz, Partner, Hogan Lovells (formerly Deputy General Counsel at HHS and Head of the Office of Compliance for Drugs at FDA)